A patient with pheochromocytoma showed remarkable improvement of myocardial metaiodobenzylguanidine (MIBG) uptake within a short time after surgical resection of the tumor. Myocardial MIBG findings in this case may contribute to an interpretation of the kinetics of MIBG in the human heart.
Get full access to this article
View all access options for this article.
References
1.
Nakajo M, Shapiro B, Glowniak JV, et al: Inverse relationship between cardiac accumulation of meta-(I-131) iodobenzylguanidine and circulating catecholamines in suspected pheochromocytoma. J Nucl Med24:1127-1134, 1983.
2.
Suga K, Tsukamoto K, Nishigauchi K, et al: Iodine-123-MIBG imaging in pheochromocytoma with cardiomyopathy and pulmonary edema. J Nucl Med37:1361-1364, 1996.
3.
Ikenobu K, Habuchi Y, Jeong S, et al: A follow up study using iodine-131 metaiodobenzylguanidine imaging in a patient with neuroblastoma. Clin Nucl Med11:777-780, 1986.
4.
Suga K, Ogasawara N, Ariga M, et al: Alteration of myocardial metaiodobenzylguanidine uptake after treatment of pheochromocytomata and neuroblastoma. Eur J Nucl Med27:574-582, 2000.
5.
Gill JS, Hunter GJ, Gane G, et al: Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled metaiodobenzylguanidine scintigraphy. Am Heart J126:390-398, 1993.
6.
Glownial BJ, Kilty JE, Amara SG, et al: Evaluation of metaiodo-benzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med34:1140-1146, 1993.
